NEW YORK, April 7 - Valentis said that it received a Nasdaq staff determination letter on March 28 for not maintaining a sufficient number of independent members of its board of directors and for violating a shareholder approval requirement.
Registering provides access to this and other free content.
Already have an account?Login Now.
Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.
DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.
A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.
In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.